Deoxyribonucleic acid cytometry and histological findings before and after 125iodine implantation of primary prostate cancer. 1992

H Waehre, and O Amellem, and A E Stenwig, and K Tverå, and M Juul, and E O Pettersen, and S D Fosså
Department of Surgical Oncology, Norwegian Radium Hospital, Oslo.

Deoxyribonucleic acid (DNA) flow cytometry and light microscopy were performed in pre-radiotherapy and post-radiotherapy biopsies obtained from the primary tumor in 31 patients with prostate cancer. Radiotherapy was applied by means of transperineal 125iodine (125I) implantation. Of the patients 21 had pretreatment biopsies and in 19 of these biopsies also were performed 1 and/or 1 1/2 years after the 125I implantation. Posttreatment biopsies were available for DNA flow cytometry in 12 additional patients without pretreatment DNA flow cytometry assessment. Of the 21 pretreatment biopsies 7 were diploid, 6 tetraploid and 8 aneuploid. All 31 posttreatment biopsies were either tetraploid (21) or aneuploid (10). All 6 pretreatment diploid tumors became tetraploid after radiotherapy. At 1 and/or 1 1/2 years after 125I implantation residual tumors were found in 28 of 31 prostatic glands. The high frequency of nondiploid DNA stemlines 1 or more years after 125I implantation and the high rate of residual tumor leave some doubt about the radiocurability of prostate cancer by the chosen radiotherapy technique.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D008297 Male Males
D011003 Ploidies The degree of replication of the chromosome set in the karyotype. Ploidy
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D001918 Brachytherapy A collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues. Curietherapy,Implant Radiotherapy,Plaque Therapy, Radioisotope,Radioisotope Brachytherapy,Radiotherapy, Interstitial,Radiotherapy, Intracavity,Radiotherapy, Surface,Brachytherapy, Radioisotope,Interstitial Radiotherapy,Intracavity Radiotherapy,Radioisotope Plaque Therapy,Radiotherapy, Implant,Surface Radiotherapy,Therapy, Radioisotope Plaque
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies

Related Publications

H Waehre, and O Amellem, and A E Stenwig, and K Tverå, and M Juul, and E O Pettersen, and S D Fosså
May 1980, The Journal of urology,
H Waehre, and O Amellem, and A E Stenwig, and K Tverå, and M Juul, and E O Pettersen, and S D Fosså
December 1986, International journal of radiation oncology, biology, physics,
H Waehre, and O Amellem, and A E Stenwig, and K Tverå, and M Juul, and E O Pettersen, and S D Fosså
January 1985, Radiation medicine,
H Waehre, and O Amellem, and A E Stenwig, and K Tverå, and M Juul, and E O Pettersen, and S D Fosså
July 1995, The Journal of urology,
H Waehre, and O Amellem, and A E Stenwig, and K Tverå, and M Juul, and E O Pettersen, and S D Fosså
December 2012, Cancer,
H Waehre, and O Amellem, and A E Stenwig, and K Tverå, and M Juul, and E O Pettersen, and S D Fosså
March 1995, The Journal of urology,
H Waehre, and O Amellem, and A E Stenwig, and K Tverå, and M Juul, and E O Pettersen, and S D Fosså
August 1988, American journal of clinical oncology,
H Waehre, and O Amellem, and A E Stenwig, and K Tverå, and M Juul, and E O Pettersen, and S D Fosså
April 1994, Acta urologica Belgica,
H Waehre, and O Amellem, and A E Stenwig, and K Tverå, and M Juul, and E O Pettersen, and S D Fosså
June 2000, Techniques in urology,
H Waehre, and O Amellem, and A E Stenwig, and K Tverå, and M Juul, and E O Pettersen, and S D Fosså
February 1999, International journal of radiation oncology, biology, physics,
Copied contents to your clipboard!